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Abstract
We reported a 24-year-old female patient with the history of ectopic axillary breast cancer which was removed surgically. Sentinel 
node mapping was performed for lymphatic axillary staging of this patient with two injections of the 99m-Tc-phytate in both 
ends of the surgical scar. Lymphoscintigraphy showed an axillary sentinel node which was harvested during surgery and was 
not pathologically involved. Our case showed that sentinel node mapping is possible for ectopic axillary breast cancer patients 
even after excisional biopsy of the index lesion.
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Background
Ectopic breast tissue can occur anywhere from axilla to groin 
on the embryonic mammary line with the incidence of 0.6 to 6% 
[1]. Malignancy can occur in these ectopic breast tissues which 
behaves the same as the orthotopic breast cancers. However, the 
prognosis of carcinoma arising from ectopic breast, due to early 
lymph node metastasis or delayed diagnosis, is worse than that of 
normal breast cancer [2]. Ectopic breast neoplasm, once detected, 
should be treated similar to the typical breast neoplasms [3, 4]. 
In case of malignant transformation in an ectopic breast tissue, 
the treatment should be directed towards standard breast cancer 
therapy. We reported a case of axillary ectopic breast cancer with the 
history of previous excisional biopsy of the lesion that was treated 
successfully with sentinel node mapping.
Case report
A 24-year-old female patient with the history of an asymptomatic 
mass in the left axilla was referred to our department for sentinel 
node mapping. The patient had undergone excisional biopsy of the 
mass 3 weeks before and invasive ductal carcinoma was proven.
Two aliquots of 99mTc-phytate (1 mCi each) were injected in both 
ends of the surgical scar 24 hours before surgery. Planar imaging 
(anterior and left lateral view) was performed 12 hours post-injection 
using dual-head variable angel gamma camera (E.CAM, Siemens) 
equipped with low energy high resolution collimator and 99mTc 
photopeak with 20% window.
The images showed an axillary sentinel node as a focal zone of 
increased tracer uptake in the left axillary region (stripped arrows). 
Injection sites were visible adjacent to the sentinel node (arrows) 
(Figure 1). During surgery, a hot sentinel lymph node was found 
(using a hand-held gamma probe) in the left axillary region, which 
was harvested. Harvested sentinel node was not pathologically 
involved in the frozen section analysis, thus lymphadenectomy 
was not performed.
Discussion
Lymph node staging should correspond to the specific lymph 
flow drainage site of the malignant tumor. Sentinel node mapping 
is a viable alternative to lymph node dissection in case of malignant 
transformation of the ectopic breast tissues [2, 5, 6]. However, our 
case had a previous history of excisional biopsy of the ectopic 
breast tissue with a scar in the axilla. Although sentinel node map-
ping is not contra-indicated in case of excisional biopsy of the 
primary breast cancer lesions [7–11], a history of previous surgery 
in the axilla is considered as a contra-indication for sentinel node 
mapping by many experts. They argue that previous axillary surgery 
can impede the lymph flow to the axilla with a resulting unacceptable 
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risk of sentinel node mapping failure [12]. On the other hand, many 
researchers reported successful sentinel node mapping following 
previous axillary surgery in breast cancer patients [13]. Our case 
showed that with proper injection of the radiotracer (in both ends of 
the surgical scar), lymphatic mapping in a previously excised axillary 
ectopic breast cancer can be successful.
Another problem with axillary ectopic breast cancer sentinel 
node mapping is the close proximity of the injection sites to axilla 
which can make intra-operative sentinel node detection very hard 
by surgical gamma probe due to high background. In our case, 
we used a two day protocol (radiotracer injection a day before 
surgery) for lymphatic mapping which can decrease the interfering 
background from the injection sites [14, 15].
Conclusion
In conclusion, sentinel node mapping is a viable method for 
lymph node staging in ectopic axillary breast cancers. History of 
excision of the primary lesion should not deter the treating physi-
cians from sentinel node mapping.
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Figure 1A, B. Lymphoscintigraphy of the patient. The images showed an axillary sentinel node  
as a focal zone of increased tracer uptake in the left axillary region (stripped arrows). Injection sites 
were visible adjacent to the sentinel node (arrows)
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